Under specific pathological conditions, downregulation of JAZF1 expression is observed, and this reduction in JAZF1 levels has been implicated in the pathogenesis of metabolic disorders such as obesity, diabetes, and hepatic steatosis [21–24]. The gene discussed is JAZF1; the disease is Hepatic steatosis.